These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 9354781)

  • 1. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition.
    Bales KR; Verina T; Dodel RC; Du Y; Altstiel L; Bender M; Hyslop P; Johnstone EM; Little SP; Cummins DJ; Piccardo P; Ghetti B; Paul SM
    Nat Genet; 1997 Nov; 17(3):263-4. PubMed ID: 9354781
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropathological characterization of mutant amyloid precursor protein yeast artificial chromosome transgenic mice.
    Kulnane LS; Lamb BT
    Neurobiol Dis; 2001 Dec; 8(6):982-92. PubMed ID: 11741394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation.
    Nilsson LN; Arendash GW; Leighty RE; Costa DA; Low MA; Garcia MF; Cracciolo JR; Rojiani A; Wu X; Bales KR; Paul SM; Potter H
    Neurobiol Aging; 2004 Oct; 25(9):1153-67. PubMed ID: 15312961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of transgenic APP mRNA is the key determinant for beta-amyloid deposition in PS2APP transgenic mice.
    Ozmen L; Albientz A; Czech C; Jacobsen H
    Neurodegener Dis; 2009; 6(1-2):29-36. PubMed ID: 19066434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic background regulates beta-amyloid precursor protein processing and beta-amyloid deposition in the mouse.
    Lehman EJ; Kulnane LS; Gao Y; Petriello MC; Pimpis KM; Younkin L; Dolios G; Wang R; Younkin SG; Lamb BT
    Hum Mol Genet; 2003 Nov; 12(22):2949-56. PubMed ID: 14506131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease-like neuropathology of gene-targeted APP-SLxPS1mut mice expressing the amyloid precursor protein at endogenous levels.
    Köhler C; Ebert U; Baumann K; Schröder H
    Neurobiol Dis; 2005 Nov; 20(2):528-40. PubMed ID: 15921918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E, amyloid, and Alzheimer disease.
    Bales KR; Dodart JC; DeMattos RB; Holtzman DM; Paul SM
    Mol Interv; 2002 Oct; 2(6):363-75, 339. PubMed ID: 14993413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid deposition in the hippocampus and entorhinal cortex: quantitative analysis of a transgenic mouse model.
    Reilly JF; Games D; Rydel RE; Freedman S; Schenk D; Young WG; Morrison JH; Bloom FE
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4837-42. PubMed ID: 12697936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E isoforms in Alzheimer's disease pathology and etiology.
    Baum L; Chen L; Ng HK; Pang CP
    Microsc Res Tech; 2000 Aug; 50(4):278-81. PubMed ID: 10936880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of estrogen receptor beta in mice brain results in pathological alterations resembling Alzheimer disease.
    Zhang QH; Huang YH; Hu YZ; Wei GZ; Han XF; Lu SY; Zhao YF
    Acta Pharmacol Sin; 2004 Apr; 25(4):452-7. PubMed ID: 15066212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein.
    Lee KW; Im JY; Song JS; Lee SH; Lee HJ; Ha HY; Koh JY; Gwag BJ; Yang SD; Paik SG; Han PL
    Neurobiol Dis; 2006 Apr; 22(1):10-24. PubMed ID: 16289866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice.
    Thal DR; Larionov S; Abramowski D; Wiederhold KH; Van Dooren T; Yamaguchi H; Haass C; Van Leuven F; Staufenbiel M; Capetillo-Zarate E
    Neurobiol Aging; 2007 Aug; 28(8):1221-30. PubMed ID: 16815595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
    Dolev I; Michaelson DM
    Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances fuel Alzheimer's conundrum.
    Mattson MP
    Nat Genet; 1997 Nov; 17(3):254-6. PubMed ID: 9354778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.